Full-Time
Confirmed live in the last 24 hours
Global provider of dental products and technologies
$99.7k - $185.2kAnnually
Senior
Remote in USA
Targeting candidates located on the East Coast of the United States.
You match the following Envista's candidate preferences
Employers are more likely to interview you if you match these preferences:
Envista provides a wide range of dental products and services aimed at supporting dental professionals in their work. Their product portfolio includes dental implants, orthodontics, and digital imaging technologies, which together address about 90% of the clinical needs for diagnosing, treating, and preventing dental conditions. Envista's products work by offering tools and solutions that enhance the capabilities of dental professionals, allowing them to create healthier and more aesthetically pleasing smiles for their patients. What sets Envista apart from its competitors is its commitment to continuous improvement and a strong partnership approach, positioning itself as a champion for dental professionals. The company's goal is to empower these professionals to excel in their practice and to foster a supportive community that celebrates collaboration and excellence.
Company Size
1,001-5,000
Company Stage
IPO
Total Funding
N/A
Headquarters
Brea, California
Founded
2004
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Performance Bonus
BREA, Calif., Feb. 4, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will hold a Capital Markets Day on Wednesday, March 5, from 9:00 a.m. to 12:00 p.m. EST. This event will include a management presentation followed by a question-and-answer session. In-person attendance requires advanced registration
QUAKERTOWN, PENNSYLVANIA / ACCESS Newswire / February 3, 2025 / DEXIS, an international leader in dental imaging technologies, celebrates the 2024 launch of its DEXIS digital ecosystem along with other AI-powered imaging solutions. The company also announces that 2025 will bring further innovations, with presentations at two major dental technology conferences."For DEXIS, 2024 was a year of tremendous innovation, as we continue to provide dental professionals with the most powerful, efficient and time-saving diagnostic tools and technologies," DEXIS President Robert Befidi said. "We are proud of our progress and will bring that momentum with us in 2025 as we unveil exciting, industry-changing initiatives."The company enhanced its portfolio of award-winning imaging solutions in 2024, beginning with the February 2024 launch of the DEXIS digital ecosystem , a suite of tools and software designed to connect and streamline the implant workflow. The platform combines cutting-edge CBCT, intraoral scanning, diagnostics, and treatment planning to aid clinicians through their entire digital workflow from diagnosis to delivery. The open imaging system ensures that clinicians have the freedom to customize workflows and that patients, labs, and staff have the appropriate visibility, creating a seamless experience.May 2024 brought the release of the DEXIS Ti2 Intraoral Sensor , built on the success of its predecessor, the best-selling DEXIS Titanium Sensor. The Ti2 sensor provides high-resolution images while also adding 2D AI Dental Findings, an integrated offering that automatically identifies and highlights 6 common dental findings
BREA, Calif., Jan. 27, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2024 on Wednesday, February 5, 2025. Envista is moving the time of the conference call and will now discuss these results beginning at 2:30 PM PT on the same date. The call will last approximately one hour.The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. You can access the conference call by dialing 800-225-9448 within the U.S
BREA, Calif., Jan. 14, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2024 on Wednesday, February 5, 2025. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour.The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. You can access the conference call by dialing 800-225-9448 within the U.S. or +1 203-518-9708 outside the U.S
BREA, Calif., Jan. 7, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in a presentation at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, from 9:45 – 10:25 am PT at the Westin St. Francis Hotel in San Francisco. There will be an audio-only recording link that can be viewed on Envista's Investor Relations website for up to 30 days following the event.ABOUT ENVISTA HOLDINGS CORPORATIONEnvista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services